atezolizumab,cobimetinib,talazoparib,abemaciclib,pembrolizumab,regorafenib,sunitinib,temsirolimus,palbociclib,ipilimumab,larotrectinib,vemurafenib,olaparib,futibatinib,crizotinib,nivolumab,trastuzumab,entrectinib,tucatinib,pertuzumab
seagen,merck,eli lilly,bayer,bms,roche,astrazeneca,pfizer,otsuka
['tapur']
excited to present 2 #tapur posters at #aacr23 
I am a medical oncologist and the Principal Investigator of the American Society of Clinical Oncology TAPUR study. Tweets are my own.